Women’s Health & OB/GYN News

CHICAGO — Menopausal women who participated in weekly cognitive behavioral therapy sessions reported improvements in sexual function and depression and anxiety symptoms, researchers reported at the Annual Meeting of The Menopause Society.

The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

CHICAGO — A meta-analysis suggests clinical hypnosis is more effective than cognitive behavioral therapy for reducing hot flash frequency and severity for menopausal women, researchers said at the Annual Meeting of The Menopause Society.

The combination of pembrolizumab and chemoradiotherapy significantly improved OS for women with high-risk locally advanced cervical cancer, according to results of a randomized phase 3 trial presented at ESMO Congress.

Exposure to air pollution over a half-decade increased the risk for infertility in men, the results of a nationwide cohort study published in BMJ showed.

CHICAGO — Busy women physicians have much to gain by seeking out small moments of self-care, reflecting on ways to make positive change and sharing their personal stories with other women to build a more connected community.

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker at the Annual Meeting of The Menopause Society.

CHICAGO — In this Healio video exclusive, Susan D. Reed, MD, MPH, MS, past president of The Menopause Society, highlights a new pilot program created to improve funding for research in menopause health, with up to four awards of $25,000 each.